CSI Market
Sign In | Register

Rxo Inc (RXO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access RXO quarterly Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Rxo Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Operating Activities
Income-100.00
Depreciation & amortization116.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss12.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation29.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Operating Lease Impairment Loss-
Income taxes-21.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-5.00
Increase (Decrease) in Accounts Payable-16.00
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities2.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets19.00
Other Working Capital0.00
Other Noncash Income (Expense)11.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.00
Discontinued operations0.00
Net Cash flow from Operating Activities51.00
Investing Activities
Capital Expenditures-59.00
Sale of Capital Items2.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-10.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-4.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-71.00
Financing Activities
Short-term debt Net33.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-2.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-1.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-29.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.00
Effect of exchange rate on cash flow2.00
Discontinued operations0.00
Free Cash Flow-6.00
Total Cash Flow-17.00
4 historic quarters locked

Sign in to unlock the full Rxo Inc cash flow history.

Sign In Create Free Account

About Rxo Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 9, 2026
  • Source: rxo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001929561-26-000013

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License